---
type: "Symbol"
title: "SILVER CREST ACQUISITION CORP (SLCR.US) — 社區討論"
description: "該股票的社區討論，包括分析師觀點、財報解讀和投資策略，來自認證金融專業人士和活躍投資者。"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SLCR.US/topics.md"
symbol: "SLCR.US"
parent: "https://longbridge.com/zh-HK/quote/SLCR.US.md"
count: 1
datetime: "2026-03-14T12:58:18.401Z"
locales:
  - [en](https://longbridge.com/en/quote/SLCR.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLCR.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLCR.US/topics.md)
---

# SILVER CREST ACQUISITION CORP (SLCR.US) — 社區討論

### [In ancient Rome, 12~15 silver = 1 gold; Augustus e…](https://longbridge.com/zh-HK/topics/38112236.md)

- 作者: [奇迹的交易员cola](https://longbridge.com/zh-HK/profiles/10743314.md)
- 日期時間: 2026-01-26T17:25:39.000Z
- 評論: 40
- In ancient Rome, 12~15 silver = 1 gold; Augustus established a 1:25 gold-silver ratio as the official standard. In the later period of the empire, due to financial difficulties, the silver content of 

**評論:**

- **李迦纵 · 2026-01-26T18:23:42.000Z · 👍 6**: I believe the essence is the crisis of confidence in fiat currency. The US dollar cannot suppress gold, and gold is regaining its monetary attributes, indirectly causing silver to regain its attributes as a medium for daily transactions.
- **嘿嘿^ · 2026-01-26T18:12:45.000Z · 👍 9**: It has little to do with hedging 🫠. Fiat currencies under fiscal pressure are depreciating, while massive funds are driving up asset prices. In reality, the currency is depreciating, but silver remains at the same price.
- **Mansion（买入即跌） · 2026-01-26T18:10:38.000Z · 👍 2**: The turnover rate has reached 30%. Do you think it's reasonable for the price to keep soaring until the turnover rate reaches 50%?
- *[... 35 more comments →](https://longbridge.com/zh-HK/topics/38112236.md)*

## 參考連結

- [SILVER CREST ACQUISITION CORP (SLCR.US)](https://longbridge.com/zh-HK/quote/SLCR.US.md)


> 支持的語言: [English](https://longbridge.com/en/quote/SLCR.US/topics.md) | [简体中文](https://longbridge.com/zh-CN/quote/SLCR.US/topics.md)